Pacific Horizon Ventures
Pacific Horizon Ventures is a Seattle-based venture capital firm, with national presence, focused on the life science and healthcare
Business Model:
Revenue: $15.4M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Pacific Horizon Ventures Information
Geographic Data
Address: 500 Union Street Suite 835
City: Seattle
State: WA
Zip: 98101
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Pacific Horizon Ventures is a Seattle-based venture capital firm, with national presence, focused on the life science and healthcare industries. Since 1993, they have executed a hands-on, capital efficient strategy that is focused on early-stage life science technologies that address significant healthcare problems in poorly served markets. They are organized to deliver just-in-time general management to a select number of portfolio companies that have the potential to deliver extremely high financial returns.
Contact Phone:
+12066821181
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/1998 | Proxim Wireless | Venture Round | 22.4M |
| 3/2003 | iScience Interventional | Series B | 7M |
| 10/2004 | Argos Therapeutics | Venture Round | - |
| 3/2004 | TransMolecular | Series C | 0 |
| 3/2003 | iScience Surgical | Series B | 0 |
| 5/2006 | ViaCyte | Venture Round | 0 |
| 6/2007 | Koronis Pharmaceuticals | Series D | 20M |
| 2/2002 | Inhibitex | Venture Round | 20M |
| 3/2005 | iScience Surgical | Series C | 0 |
| 9/2000 | TransMolecular | Series B | 0 |
| 7/2007 | ViaCyte | Series C | 0 |
| 7/2007 | ViaCyte | Series C | 0 |
| 6/2007 | Koronis Pharmaceuticals | Series D | 0 |
| 5/2006 | ViaCyte | Venture Round | 0 |
| 3/2005 | iScience Surgical | Series C | 0 |
| 10/2004 | Argos Therapeutics | Venture Round | - |
| 3/2004 | TransMolecular | Series C | 0 |
| 3/2003 | iScience Interventional | Series B | 0 |
| 3/2003 | iScience Surgical | Series B | 0 |
| 2/2002 | Inhibitex | Venture Round | 0 |
| 9/2000 | TransMolecular | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
